Concurrent taVNS-fMRI Revealed Similar Brain Activation Patterns Elicited by Stimulation of the Mastoid and the Cymba Conchae.
Xiaolong Peng, Stewart S Cox, Falon Sutton...
https://pubmed.ncbi.nlm.nih.gov/42268178/Actively Recruiting
Led by Nationwide Children's Hospital · Updated on 2026-09-01
30
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying the use of transcutaneous auricular neurostimulation with the Sparrow Link device as a treatment for adolescents aged 12 to 18 years who have abdominal pain related to disorders of gut-brain interaction. This pilot study aims to evaluate adherence, retention, safety, and preliminary effects on abdominal pain, bowel symptoms, quality of life, and anxiety in this group. Participants will use the wearable Sparrow Link device on their left ear for at least one hour daily over a period of 4 weeks. The device delivers noninvasive electrical stimulation through self-adhesive electrodes placed around the ear with specific frequency and pulse settings. After the 4-week intervention, participants will continue with follow-up assessments through week 8. During the study, participants will complete questionnaires to track abdominal pain, bowel symptoms, quality of life, and anxiety from baseline through week 8. Researchers will monitor how well participants follow the treatment, how many complete the study, and any safety concerns. The total participation will last 8 weeks, including treatment and follow-up periods.
CONDITIONS
Transauricular Neurostimulation for Abdominal Pain Due to DGBI
P
Peter Lu, MD
E
Eduardo Castillo Leon, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Nationwide Children's Hospital
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Investigational transauricular neurostimulation | Current noninvasive auricular neurostimulation |
|---|---|---|
| What it is | A wearable external ear device (Sparrow Link) delivering daily transcutaneous electrical stimulation via electrodes placed on and around the ear for at least 1 hour per day over 4 weeks, with follow-up through week 8 | Percutaneous electrical nerve field stimulation (PENFS), a noninvasive auricular neurostimulation therapy applied behind or on the ear, studied in pediatric DGBI for abdominal pain relief |
| Role in trial | Participants receive the active Sparrow Link device as the sole intervention in an open‑label single‑group pilot study | Not evaluated in this trial, but represents an external counterpoint therapy used in routine practice for similar patients |
| Primary use | To treat abdominal pain due to DGBI in adolescents by modulating auricular nerve activity | To relieve abdominal pain in pediatric disorders of gut‑brain interaction using noninvasive ear‑based nerve stimulation |
| How it is given or performed | Self‑applied wearable device on the left ear delivering 30 Hz and 100 Hz pulses alternating via electrodes, for 1 hour daily over 4 weeks | Clinician‑placed small electrodes on or behind the ear deliver continuous nerve field stimulation over treatment cycles such as 4‑week periods |
| Evidence status | Efficacy and safety not yet established; this pilot will assess adherence, retention, preliminary changes in pain and quality of life through week 8 | PENFS has demonstrated symptom improvement and quality‑of‑life gains in pediatric DGBI in single‑center and multicenter studies |
| Important risks | Risk information not yet established; device safety will be observed during the study | PENFS has shown a high safety profile with minimal reported side effects in pediatric studies |
| Important limitations | Open‑label single‑group design without control limits ability to determine treatment effect versus placebo or natural history | Evidence largely from non‑randomized and registry studies; access may be limited by clinician training and reimbursement challenges |
| Patient impact | Not yet established—outcomes pending study completion | Symptom relief and quality‑of‑life improvements observed in pediatric patients with DGBI using PENFS |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 4 weeks
Participants use the Sparrow Link device on their left ear for at least one hour daily to receive electrical stimulation over 4 weeks.
Duration - 4 weeks
Participants complete questionnaires and assessments through week 8 to evaluate changes in pain, bowel symptoms, quality of life, and anxiety.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Xiaolong Peng, Stewart S Cox, Falon Sutton...
https://pubmed.ncbi.nlm.nih.gov/42268178/Carlos F Tirado, Stephanie N Washburn, Alejandro Covalin...
https://pubmed.ncbi.nlm.nih.gov/35978394/Nationwide Children's Hospital
Lead Sponsor